Vision

GWOXI aims to set a global benchmark in regenerative medicine by translating stem cell research into clinically validated therapies. Our goal is to become Taiwan’s first company to obtain regulatory approval for mesenchymal stem cell–based pharmaceuticals, building on a solid foundation in Taiwan while expanding our impact internationally.

Aligned with six strategic goals, GWOXI continues to expand its expertise in the field of cell therapy, while focusing on innovation, commercialization, marketing, and human resource development to attract and retain top talent.